These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21919891)

  • 1. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
    Wu KJ; Yang MH
    Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct activation of Bmi1 by Twist1: implications in cancer stemness, epithelial-mesenchymal transition, and clinical significance.
    Wu KJ
    Chang Gung Med J; 2011; 34(3):229-38. PubMed ID: 21733352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage between Twist1 and Bmi1: molecular mechanism of cancer metastasis/stemness and clinical implications.
    Wu CY; Hung JJ; Wu KJ
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):668-73. PubMed ID: 21883379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenesis: Twist1 links EMT to self-renewal.
    Martin A; Cano A
    Nat Cell Biol; 2010 Oct; 12(10):924-5. PubMed ID: 20885418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition.
    Yang MH; Hsu DS; Wang HW; Wang HJ; Lan HY; Yang WH; Huang CH; Kao SY; Tzeng CH; Tai SK; Chang SY; Lee OK; Wu KJ
    Nat Cell Biol; 2010 Oct; 12(10):982-92. PubMed ID: 20818389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
    Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
    Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
    J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
    Yonemitsu Y; Imazeki F; Chiba T; Fukai K; Nagai Y; Miyagi S; Arai M; Aoki R; Miyazaki M; Nakatani Y; Iwama A; Yokosuka O
    Hum Pathol; 2009 Sep; 40(9):1304-11. PubMed ID: 19386347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer.
    Pietersen AM; Horlings HM; Hauptmann M; Langerød A; Ajouaou A; Cornelissen-Steijger P; Wessels LF; Jonkers J; van de Vijver MJ; van Lohuizen M
    Breast Cancer Res; 2008; 10(6):R109. PubMed ID: 19099573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A twist tale of cancer metastasis and tumor angiogenesis.
    Tseng JC; Chen HF; Wu KJ
    Histol Histopathol; 2015 Nov; 30(11):1283-94. PubMed ID: 26084282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
    Aoki R; Chiba T; Miyagi S; Negishi M; Konuma T; Taniguchi H; Ogawa M; Yokosuka O; Iwama A
    J Hepatol; 2010 Jun; 52(6):854-63. PubMed ID: 20395008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different levels of Twist1 regulate skin tumor initiation, stemness, and progression.
    Beck B; Lapouge G; Rorive S; Drogat B; Desaedelaere K; Delafaille S; Dubois C; Salmon I; Willekens K; Marine JC; Blanpain C
    Cell Stem Cell; 2015 Jan; 16(1):67-79. PubMed ID: 25575080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HR23A-knockdown lung cancer cells exhibit epithelial-to-mesenchymal transition and gain stemness properties through increased Twist1 stability.
    Yu CY; Liu BH; Tang SY; Liang RY; Hsu KH; Chuang SM
    Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118537. PubMed ID: 31487504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.
    Talati PG; Gu L; Ellsworth EM; Girondo MA; Trerotola M; Hoang DT; Leiby B; Dagvadorj A; McCue PA; Lallas CD; Trabulsi EJ; Gomella L; Aplin AE; Languino L; Fatatis A; Rui H; Nevalainen MT
    Am J Pathol; 2015 Sep; 185(9):2505-22. PubMed ID: 26362718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.